Home
overview

Cancer Vaccines helps to boost the immune system's recognition and resistance to cancer cells. Thus, increased knowledge of our immune system has opened up new combination therapies in immuno-oncology, to enhance immune response, as some the latest treatments incorporate monoclonal antibodies and genetically engineered viral vectors to kill tumours.

In addition, two- panel discussions on both days will bring some key questions to light including the commercial viability of personalised treatments.


 

Some of the hottest topics will include:
• CAR T-Cell Therapy
• Oncolytic viral therapies
• Gene-therapy
• Adoptive T-Cell transfer

However, it has also become clear that cancer cells have different ways of eluding the immune system, which makes creating effective vaccines difficult.

Researchers are also studying the best way to give vaccines, looking to see if they work better when used alone or with other types of cancer treatments. Therefore key discussion points in our 2-day interactive panel will include:

  • Development of combination treatments - which ones are best?
  • Driving the next generation tools in cancer immunotherapy
  • How will technology and data systems need to change in order to allow personalised treatment to evolve?

Our conference features some important talks from leading biotechs, academics and pharma including:

  • Integrating platforms for the discovery of new cancer biomarkers
  • Epitope design enables a pipeline of Multi-Antigen DNA Tumor Vaccines
  • Deriving allogeneic dendritic cells for future scalability and feasibility of cellular cancer vaccines
  • Optimizing Formulation Development Strategies for Vaccine Adjuvants 


 

 

 

However, it has also become clear that cancer cells have different ways of eluding the immune system, which makes creating effective vaccines difficult.

Researchers are also studying the best way to give vaccines, looking to see if they work better when used alone or with other types of cancer treatments. Therefore key discussion points in our 2-day interactive panel will include:

  • Development of combination treatments - which ones are best?
  • Driving the next generation tools in cancer immunotherapy
  • How will technology and data systems need to change in order to allow personalised treatment to evolve? 



 

This conference is ideal for professionals involved in the following areas:

  • Cancer Immunotherapeutics
  • Vaccine developement
  • Clinical Trials
  • RNA-based vaccine development
  • Vaccine delivery systems
  • Angionesis

 

Aldevron; Amal Therapeutics; Amgen Ltd; Boehringer Ingelheim RCV GmbH & Co KG; Cancer Research UK; Cancer Vaccines Ltd; Cobra Biologics; Crucell Vaccine Institute; Curevac GmbH; DanDrit Biotech; DROIA nv; EGIS Pharmaceuticals PLC; Genelux Corporation; GSK; Hybrid Systems Ltd; Immatics Biotechnologies GmbH; Immudex; Immunicum; Immunicum AB; IPI (International Pharmaceutical Industry); KACST; MediGene AG; Northwest Biotherapeutics; Northwest Biotherapeutics Inc; Ross University School Of Medicine; Sartorius Stedim Biotech; Scancell Limited; St George Hospital ; Theravectys; Thomson Reuters; University of Liverpool; University Of Pennsylvania; University Of Southampton; University Of Tuebingen; Vaccinogen; Valneva; XEME Biopharma Inc;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Farzin Farzaneh

Farzin Farzaneh Professor of Molecular Medicine, Kings College London

9:10 OPENING ADDRESS: The Provocative Issue of Tumor Genetic Heterogeneity in Immunotherapy

Michael G. Hanna, Jr.

Michael G. Hanna, Jr. Founder & Chairman Emeritus, Vaccinogen, Inc.

 

  • You cannot treat a Heterogeneous disease with a Homogeneous treatment.
  •  Immunotherapy should be aimed at preventing recurrence not treating established tumors
  •  Immune longevity in Autologous Vaccine Immunotherapy
  • 9:50 Sponsored session: An introduction to Assays for Immune-Modulators and Immunotherapy on the iQue® Screener

    Miles Rackliff

    Miles Rackliff UK Sales Manager, IntelliCyt

    Matt Johnson

    Matt Johnson CTO, Avacta Life Sciences

    10:30 Morning Coffee

    11:00 Translational Biomarkers and Diognostic Tools in Oncology

    Vaios Karanikas

    Vaios Karanikas Biomarker Experimental Medicine Leader, Tumour Immunology, Roche Innovation Center Zurich

  •  Analysis and interpretation of biomarker data to suppport key decision making during early clinical development
  • Enabling strategies and their implimentation for early preclinical/ clinical studies
  • Validating the predictive utility of biomarker candidates
     
     
  • 11:40 Establishing a fully-personalised cancer treatment

    Dr. Ravi Madan

    Dr. Ravi Madan , National Cancer Institute

     

    ·          Phase I/II clinical trials
    ·          Augmenting T Cell response
    ·          Vaccine and checkpoint blockade combinations

    12:20 Networking Lunch

    13:30 Sponsored Session: DCVax®: Novel Personalized Immune Therapies for Solid Tumors

    Linda F. Powers

    Linda F. Powers Chair and CEO, Northwest Biotherapeutics

  • Ms. Powers will discuss NW Bio’s DCVax® platform technology, a personalized, dendritic cell based active immunotherapy for solid tumors.
  •  Unlike conventional cancer drugs and other immune therapies, which use one active agent to hit one target on the cancer, DCVax mobilizes many active agents of the immune system to hit many targets on the cancer.

     

  • 14:10 Industry Perspective: Combination therapies to advance immune-oncology vaccines and enhance patient outcomes

    Thomas Felzmann

    Thomas Felzmann CEO, Activartis Biotech GmbH

     

    ·          Multi-modal cancer immunotherapy – combining vaccines & ICP inhibitors
    ·          Prognostic and Predictive Markers to Support Identification of Effective Immunotherapy Combinations
    ·          Case study

    14:50 Afternoon Tea

    15:20 Four into One does go: The use of integrated genomic, proteomic, immunological and bioinformatic platforms to identify novel immunological biomarkers of disease and predict outcomes of disease

    Graham Pockley

    Graham Pockley Associate Director & Professor of Immunobiology , Nottingham Trent University

     

    ·       Tumour-mediated immunoregulation and immunological barriers to successful therapeutic outcomes
    ·       Immunomics: Integrating platforms for the discovery of new cancer biomarkers
    ·       Case Study: Immunomics in prostate and breast cancer

    16:00 Oncolytic virotherapy: cancer immunotherapy as nature intended

    Hardev Pandha

    Hardev Pandha Professor of Medical Oncology, Consultant Physician in Medical Oncology, University of Surrey

    16:40 Who is afraid about Bacterial Ghosts

    Werner Lubitz

    Werner Lubitz CEO, BIRD-C GmbH & CoKEG

  • Biological active delivery vehicles
  • Adjuvant particles
  • Cancer immunotherapy

     

  • 17:20 PANEL DISCUSSION: Where is the Future for Cancer Vaccines?

    Farzin Farzaneh

    Farzin Farzaneh Professor of Molecular Medicine, Kings College London

    Dr. Ravi Madan

    Dr. Ravi Madan , National Cancer Institute

    Linda F. Powers

    Linda F. Powers Chair and CEO, Northwest Biotherapeutics

    Sebastian Kreiter

    Sebastian Kreiter VP Immunotherapy , BioNTech RNA Pharmaceuticals

    Werner Lubitz

    Werner Lubitz CEO, BIRD-C GmbH & CoKEG

     

    ·          When should we use personalised and non-personalised care?
    ·          How can we develop further understanding in identifying novel pathways
    ·          How accessible would fully- personalised treatments become? 
    ·          How will technology and data systems need to change in order to allow personalised treatment to evolve?

    18:00 Chairman’s Closing Remarks and Close of Day One

    Werner Lubitz

    Werner Lubitz CEO, BIRD-C GmbH & CoKEG

    18:10 Drinks Reception Sponsored by Northwest Biotherapeutics

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Farzin Farzaneh

    Farzin Farzaneh Professor of Molecular Medicine, Kings College London

    9:10 Therapeutic Cancer Vaccines

    Farzin Farzaneh

    Farzin Farzaneh Professor of Molecular Medicine, Kings College London

     

    ·          Tumour immunology and interactions between cancer and the immune system
    ·          Immune based sculpting of the tumour - selection of the most resistant cancer cells
    ·          Cancer mediated immune suppression – inhibition of surveillance and stimulation of immune check points
    ·          New therapeutic interventions: Active vaccination strategies, check point inhibition and targeted cytotolytic cells (CARs and TCR modified T cells)

    9:50 RNA- vaccinology: From ware-houses to actively personalized cancer vaccines

    Sebastian Kreiter

    Sebastian Kreiter VP Immunotherapy , BioNTech RNA Pharmaceuticals

     

     

    ·          Simulating tumour-specific antigen recognition
    ·          Epitope design enables a pipeline of Multi-Antigen DNA Tumor Vaccines
    ·          Neo-antigen–specific CD4+ T cells recognize mutated neo-antigens

    10:30 Morning Coffee

    11:00 Developments and clinical trials in allogeneic cell-based vaccines

    John Maudsley

    John Maudsley CEO, Cancer Vaccines Ltd

     

    ·          Deriving allogeneic dendritic cellsfor future scalability and feasibility of cellular cancer vaccines
    ·          Practicalities of vaccine clinical trials
    ·          Cancer vaccine trial designs
    ·          Implementing targeting of known tumour antigens

    11:40 Afternoon chair opening address: Case study: Dendritic cell vaccine development for colorectal cancer

    Eric Leire

    Eric Leire CEO, DanDrit Biotech

    12:20 Networking Lunch

    13:30 Differentiation pathways of effector and memory CD8+ T cells

    Aymen Al-Shamkhani

    Aymen Al-Shamkhani Professor in Immunology, University Of Southampton

     

     

    ·         The protective role of memory CD8+ T cell subsets
    ·         Signalling pathways that regulate effector and memory CD8+ T cell generation
    ·         Memory T cell subsets generated by vaccines and natural infection

    14:10 Long-term maintenance of T cell memory by liposomes

    Else Marie Agger

    Else Marie Agger Director, Statens Serum Institut

    14:50 Round table discussion: Engineering materials to improve immune response

    15:30 Peptides or DNA vaccines? Could Immunobody® be the answer?

    Stephanie McArdle

    Stephanie McArdle Senior Research Scientist, The John van Geest Cancer Research Centre, Nottingham Trent University

     

    ·          Long peptides vaccination require adjuvants but different peptide work best with different adjuvant
    ·          DNA vaccine do not always generate high avidity T-cells
    ·          Could Immunobody® be the Universal antigen delivery system? 

    16:10 Afternoon Tea

    16:40 PANEL DISCUSSION

    Farzin Farzaneh

    Farzin Farzaneh Professor of Molecular Medicine, Kings College London

    Eric Leire

    Eric Leire CEO, DanDrit Biotech

    Stephanie McArdle

    Stephanie McArdle Senior Research Scientist, The John van Geest Cancer Research Centre, Nottingham Trent University

    John Maudsley

    John Maudsley CEO, Cancer Vaccines Ltd

     

    ·          Are we closer to achieving sustained antitumor immune response?
    ·          Driving next generation tools in cancer immunotherapy
    ·          What progresses in the Genome-wide mutation identification initiatives have helped personalised immunology?

    17:20 Chair's Closing Remarks

    Eric Leire

    Eric Leire CEO, DanDrit Biotech

    +

    FEATURED SPEAKERS

    Dr. Ravi Madan

    Dr. Ravi Madan

    , National Cancer Institute
    Linda F. Powers

    Linda F. Powers

    Chair and CEO, Northwest Biotherapeutics
    Michael G. Hanna, Jr.

    Michael G. Hanna, Jr.

    Founder & Chairman Emeritus, Vaccinogen, Inc.
    Sebastian Kreiter

    Sebastian Kreiter

    VP Immunotherapy , BioNTech RNA Pharmaceuticals
    Thomas Felzmann

    Thomas Felzmann

    CEO, Activartis Biotech GmbH
    Vaios Karanikas

    Vaios Karanikas

    Biomarker Experimental Medicine Leader, Tumour Immunology, Roche Innovation Center Zurich

    Aymen Al-Shamkhani

    Professor in Immunology, University Of Southampton
    Aymen Al-Shamkhani

    Dr. Ravi Madan

    , National Cancer Institute
    Dr. Ravi Madan

    Else Marie Agger

    Director, Statens Serum Institut
    Else Marie Agger

    Eric Leire

    CEO, DanDrit Biotech
    Eric Leire

    Farzin Farzaneh

    Professor of Molecular Medicine, Kings College London
    Farzin Farzaneh

    Graham Pockley

    Associate Director & Professor of Immunobiology , Nottingham Trent University
    Graham Pockley

    Hardev Pandha

    Professor of Medical Oncology, Consultant Physician in Medical Oncology, University of Surrey
    Hardev Pandha

    John Maudsley

    CEO, Cancer Vaccines Ltd
    John Maudsley

    Linda F. Powers

    Chair and CEO, Northwest Biotherapeutics
    Linda F. Powers

    Matt Johnson

    CTO, Avacta Life Sciences
    Matt Johnson

    Michael G. Hanna, Jr.

    Founder & Chairman Emeritus, Vaccinogen, Inc.
    Michael G. Hanna, Jr.

    Miles Rackliff

    UK Sales Manager, IntelliCyt
    Miles Rackliff

    Sebastian Kreiter

    VP Immunotherapy , BioNTech RNA Pharmaceuticals
    Sebastian Kreiter

    Stephanie McArdle

    Senior Research Scientist, The John van Geest Cancer Research Centre, Nottingham Trent University
    Stephanie McArdle

    Thomas Felzmann

    CEO, Activartis Biotech GmbH
    Thomas Felzmann

    Vaios Karanikas

    Biomarker Experimental Medicine Leader, Tumour Immunology, Roche Innovation Center Zurich
    Vaios Karanikas

    Werner Lubitz

    CEO, BIRD-C GmbH & CoKEG
    Werner Lubitz

    Sponsors and Exhibitors

    Official Media Partner

    Supporters

    ASSOCIATED EVENTS

    Tumour Genomic Heterogeneity in Immunotherapies
    Workshop

    Tumour Genomic Heterogeneity in Immunotherapies

    Marriott Hotel Regents Park
    15th September 2015
    London, United Kingdom

    VENUE

    Marriott Regents Park

    128 King Henry's Road, London, United Kingdom

    This 4 star north London hotel in zone 2 is the perfect destination for the astute business traveler as well as the leisure guest that knows how convenient north London hotels are, as a base from which to explore the city .Bond Street is just 3 stops from Swiss Cottage underground station on the Jubilee Line, so you can be shopping, exploring the sights and taking in one of London’s world-renowned West End shows in less than 15 minutes when you stay at this hotel near central London. At the same time, the hive of activity that is Camden Town, the chic shops, cafes and restaurants of Primrose Hill and ZSL’s London Zoo in Regents Park are all just a short walk from this hotel in north London.

    HOTEL BOOKING FORM

    Is your name on the list?

    Download

    An Interview with Graham Pockley, Professor of Immunobiology

    Download

    An interview with Sebastian Kreiter, VP of Immunotherapy at BioNTech RNA Pharmaceuticals

    Download

    An interview with Activartis GmbH

    Download

    Sponsors


    Northwest Biotherapeutics

    Lead Sponsors
    http://www.nwbio.com/

    Northwest Bio is developing DCVax dendritic cell-based immunotherapeutic cancer vaccines designed to treat a broad range of solid tumor cancers more effectively than current treatments, and without the side effects of chemotherapy. The Company’s lead product, DCVax-L, is currently in a 348-patient Phase III trial for patients with newly diagnosed Glioblastoma multiforme (GBM), the most aggressive and lethal brain cancer. The Company’s second product, DCVax-Direct, is currently in a 60-patient Phase I/II trial for direct injection into all types of inoperable solid tumor cancers.


    IntelliCyt

    Sponsors and Exhibitors
    http://www.intellicyt.com

    IntelliCyt develops enabling high throughput/high content tools to profile suspension cells and their components to gain deeper insight into normal and disease processes, informing drug discovery and development and the diagnosis of disease. IntelliCyt’s platform is used worldwide in all of the top pharmaceutical, biotechnology, and bioscience research organizations.

    Media Partners


    BMC Cancer

    Official Media Partner
    http://www.biomedcentral.com/bmccancer

    BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.


    Cancer Biomarkers (CBM)

    Official Media Partner
    http://www.iospress.nl/journal/cancer-biomarkers/

    Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion. The disease markers may include, but are not limited to, genomic, epigenomic, proteomics, cellular and morphologic, and genetic factors predisposing to the disease or indicating the occurrence of the disease. Manuscripts on these factors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation will be accepted.


    DNAvaccine.com

    Official Media Partner
    http://www.dnavaccine.com/

    The DNA Vaccine Web was launched in 1995 by Robert Whalen. This eventually became DNAvaccine.com and has always been a central resource to the fields of DNA vaccinology and non-viral gene transfer. DNAvaccine.com has helped to teach people about nucleic acid vaccines, find funding opportunities, define collaborative networks, launch new companies, and much more.


    International Society of Vaccines (ISV)

    Official Media Partner
    https://www.isv-online.org



    Journal for ImmunoTherapy of Cancer

    Official Media Partner
    http://www.immunotherapyofcancer.org/

    Journal for ImmunoTherapy of Cancer is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.


    Journal of Chemotherapy

    Official Media Partner
    http://www.maneyonline.com/loi/joc

    Journal of Chemotherapy is an international multidisciplinary journal committed to the rapid publication of high quality, peer-reviewed, original research. The Journal publishes original experimental and clinical research articles, reviews, brief communications and letters on all aspects of antimicrobial, anticancer and immunomodulating chemotherapy. Review articles by authoritative experts on new trends and developments in the relevant fields are also invited.


    New Medicine

    Official Media Partner
    http://www.nmok.net

    New Medicine's Oncology Knowledgebase is a dynamic, daily updated, fully relational, user-friendly, comprehensive resource in global drug development in oncology.


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    American Pharmaceutical Review

    Supporters
    http://www.americanpharmaceuticalreview.com

    American Pharmaceutical Review is the leading review of business and technology for the pharmaceutical industry throughout North America. Each issue offers unbiased editorial on drug delivery, information technology, research & development, analytical development and control, equipment and facility manufacturing and regulatory affairs. American Pharmaceutical keeps its 30,000 readers including senior executives, technical personnel, scientists, and others fully abreast of the latest trends and developments in the process of pharmaceutical manufacturing.


    Antibodies Online

    Supporters
    http://www.antibodies-online.com

    antibodies-online.com facilitates researchers to find the appropriate antibodies for their respective research project. As an independent and multi-vendor marketplace for research antibodies and thanks to the cooperation with more than 130 different manufacturers, a large selection of Antibodies (over 700,000), ELISA Kits (over 130,000), Secondary Antibodies (17,000), Proteins (130,000), Peptides and Isotype Controls is available. By supporting the Independent Validation Initiative and the Resource Identification Initiative, antibodies-online.com also addresses the important topics of transparent product quality and scientific reproducibility. In addition scientists receive news and detailed information about the individual antibodies from databases such as the PubMed and others.


    Bentham Science

    Supporters
    http://www.benthamscience.com/

    Bentham Science Publishers is a major STM journal publisher of 116 titles and 200 plus open access journals and print/online book series (Bentham eBooks). Bentham Science answers the information needs of the pharmaceutical and biomedical research community. Leading journals include Current Drug Metabolism (Impact Factor 5.113) and Current Medicinal Chemistry (Impact Factor 4.859): FREE online journals and information: www.benthamscience.com


    Biocompare

    Supporters
    http://www.biocompare.com

    Biocompare is the most comprehensive, in-depth, and objective website for life science product information. Thousands of scientists use Biocompare daily to quickly find the right product for their experiments rather than looking through multiple print catalogs. Visit Biocompare to find the products you need, stay informed of new technologies, read product reviews, watch product videos, and keep up-to-date on life science news. Visit: www.biocompare.com


    BioPharm Insight

    Supporters
    http://www.biopharminsight.com

    BioPharm Insight is your definitive guide to the global life sciences community. Subscribers take action on forward-looking intelligence uncovered by an independent team of investigative journalists, and make strategic business decisions using the most comprehensive and powerful real-time database of market analytics and key contacts. Featuring an intuitive and customizable online interface, BioPharm Insight provides an unrivalled capability to segment and analyse the industry with detailed and searchable profiles. Learn more at www.biopharminsight.com


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


    Bioscreening

    Supporters
    http://www.bioscreening.com



    British Pharmacological Society

    Supporters
    http://www.bps.ac.uk

    The British Pharmacological Society (BPS) is the primary UK learned society concerned with research into drugs and the way they work. Our members work in academia, industry, regulatory agencies and the health services, and many are medically qualified. The Society covers the whole spectrum of pharmacology, including laboratory, clinical, and toxicological aspects. Clinical pharmacology is the medical speciality dedicated to promoting safe and effective use of medicines for patient benefit. Clinical pharmacologists work as consultants in the NHS and many hold prominent positions in UK Universities.


    CanBiotech

    Supporters
    http://www.canbiotech.com

    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.


    Contract Biotechnology

    Supporters
    http://www.contract-biotechnology.com

    Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. We are an online R&D matching tool that connects Scientifics and organizations involved in discovery, development and delivery of new healthcare products with service and products providers worldwide. Life science information technology is undergoing a revolution. Part of that revolution involves new, unexplored business models, open innovation, open data and collaboration. If you have a project or idea that you would like to propose, develop or run, we can help. A New Collaboration Network Model for Discovery Research and Development • Effective Platform: the 95% • 5.000 registered users // > 15.000 Newsletter subscribers • Geographical background: 45,5% Europe / 37,5% North America / 16,5% Asia / 0,5% ROW • Professional background: Outsourcing Manager, Project Manager, CEO, Business Developer, CSO, Account Manager, Sales & Marketing People, Scientists, R&D. For further information, please visit our website www.contract-biotechnology.com


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    Drug Discovery World

    Supporters
    http://www.ddw-online.com

    For over a decade DDW has continued to be the ‘must read’ journal within the DD&D Arena. DDW is recognised for voicing the opinions of some of the Industry’s leading luminaries and has become a recognised platform for Industry Gurus to debate some of the more challenging technological and business issues facing the the life science industry. DDW adheres to the maxim..... ‘Turning Science into Business’ DDW examines the advances in new technologies and the associated implications within the context of developing new and efficacious therapeutics. DDW is distinguishable in that it reaches out to a global audience at both bench and boardroom level, allowing both camps to profit from the uncomplicated style of editorial but at the same time challenges our readers to look at new ways to overcome discovery bottlenecks, embrace nascent technologies and build next generation technology platforms.


    EBR

    Supporters
    http://www.samedanltd.com

    European BioPharmaceutical Review (EBR) provides a dedicated platform of communication and information for the biopharmaceutical market across Europe, North America and the rest of the world. Each quarterly issue, 10,500 copies of the magazine are distributed to our specially-targeted readership with articles on the hottest topics written by eminent commentators from the biotech scene. www.samedanltd.com


    Farmavita

    Supporters
    http://www.farmavita.net/

    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    GBI

    Supporters
    http://www.gbihealth.com/

    GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


    Inderscience Publishers

    Supporters
    http://www.inderscience.com

    Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.


    Int. J. of Immunological Studies

    Supporters
    http://www.inderscience.com/ijis

    IJIS publishes a broad range of papers on all aspects of immunology from scientists in academic and non-academic organisations as well as business and government worldwide. IJIS is the flagship journal of the Frontiers in Immunology Research Network.


    International Pharmaceutical Industry

    Supporters
    http://www.ipimediaworld.com

    IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.


    IOS Press

    Supporters
    http://www.iospress.nl

    IOS Press publishes about 120 new books and 100 international journals each year covering topics ranging from computer science and mathematics to medicine and the natural sciences. All titles in this catalogue are available online as well as in print. Many titles are covered in the most important abstracting databases, such as Thomson Reuters / ISI, MEDLINE and SciVerse Scopus. Headquartered in Amsterdam with satellite offices in the USA, Germany, India and China, IOS Press has established several strategic co-publishing initiatives. Notable acquisitions included Delft University Press in 2005 and Millpress Science Publishers in 2008. IOS Press journals are available through the highly-regarded MetaPress platform.


    Labhoo

    Supporters
    http://www.labhoo.com



    LabRoots

    Supporters
    http://www.labroots.com/

    LabRoots is a free, social networking site that enables scientists, engineers, and other technical professionals to connect, collaborate with, and learn from each other. LabRoots fosters world-wide scientific communication and incorporates the newest social networking technologies. LabRoots allows scientists to connect with each other as they describe their research interests on a myriad of unique features and tools, discovering meaningful collaborations across geographic boundaries and fields of expertise.


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    Medical News Today

    Supporters
    http://www.medicalnewstoday.com

    Medical News Today is the largest independent medical and health news site on the web - with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Pharmaceutical Outsourcing

    Supporters
    http://www.pharmoutsourcing.com

    Pharmaceutical Outsourcing, the journal dedicated to pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry to our 15,000 readers in North America.


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.


    pharmaphorum

    Supporters
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    PharmaVOICE

    Supporters
    http://www.pharmavoice.com

    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.


    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


    PMR

    Supporters
    http://www.pmrcorporate.com

    PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.


    Samedan

    Supporters
    http://www.samedanltd.com/magazine/13.

    International Clinical Trials (ICT) is a quarterly magazine edited by Dr Graham Hughes, and written by specialists at the forefront of clinical research. ICT’s coverage of operational developments ranges from adaptive designs in early phase trials through to post marketing research. ICT’s targeted readership consists of key decision makers across the pharmaceutical and biotech industries, along with contract partners and consultants. The magazine is distributed to pharmaceutical professionals in Europe and North America, and is accessed globally online. Read the latest issues, explore the ICT archive and subscribe at www.samedanltd.com/magazine/13.


    SelectScience

    Supporters
    http://www.selectscience.net/register?utm_source=Media-Partner&utm_medium=Website&utm_campaign=SMI

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover the latest drug discovery and development technologies, products and techniques with product reviews, videos, application notes and news articles. Become a member for free today.


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    Technology Networks

    Supporters
    http://www.technologynetworks.com

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    The Pharma Letter

    Supporters
    http://www.thepharmaletter.com/

    The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, backed by a team of respected writers with many years of experience in the field.

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Marriott Regents Park

    128 King Henry's Road
    London NW3 3ST
    United Kingdom

    Marriott Regents Park

    This 4 star north London hotel in zone 2 is the perfect destination for the astute business traveler as well as the leisure guest that knows how convenient north London hotels are, as a base from which to explore the city .Bond Street is just 3 stops from Swiss Cottage underground station on the Jubilee Line, so you can be shopping, exploring the sights and taking in one of London’s world-renowned West End shows in less than 15 minutes when you stay at this hotel near central London. At the same time, the hive of activity that is Camden Town, the chic shops, cafes and restaurants of Primrose Hill and ZSL’s London Zoo in Regents Park are all just a short walk from this hotel in north London.

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 2nd Floor South, Harling House, 47-51 Great Suffolk Street, London, SE1 0BS, United Kingdom, Link to Map
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.